|
| Research progress of Tongxinluo Capsule in the treatment of heart failure after myocardial infarction |
| Hits 1077 Download times 770 Received:June 13, 2020 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2020.09.26 |
| Key Words
heart failure after myocardial infarction;vessel-collateral theory;Tongxinluo Capsule;myocardial reperfusion injury;myocardial no reflow |
| Author Name | Affiliation | E-mail | | MI Hongying | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | SONG Hongxia | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | LI Yawen | Hebei University of Chinese Medicine, Shijiazhuang 050091, China | | | ZHANG Wei | Shijiazhuang Maternal and Child Health Hospital, Shijiazhuang 050091, China | | | SUN Yonghui | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | GU Huihui | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | ZHANG Fenghong | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | WANG Shumin | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | CUI Jing | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | JIA Mengmeng | Hebei Yiling Hospital, Shijiazhuang 050091, China | | | JIA Zhenhua | Hebei Yiling Hospital, Shijiazhuang 050091, China
Hebei University of Chinese Medicine, Shijiazhuang 050091, China | mibeibei66@126.com |
|
| Abstract
|
| Heart failure after myocardial infarction (post infarction heart failure) as the most common and dangerous complication of patients with myocardial infarction,has brought great threat to people's health and life. Tongxinluo Capsule,which was developed under the guidance of “vessel-collateral theory” founded by Professor WU Yiling,is a representative prescription for dredging collaterals. It has been proved by research that it can improve heart function,increase cardiac output,reduce serum inflammatory factors level,reduce myocardial reperfusion injury and no reflow phenomenon,slow down the process of ventricular remodeling,delay the progress of post infarction heart failure,significantly reduce the mortality of heart failure after myocardial infarction and improve the prognosis of patients. |
|
|
|
|
|
|
|
